Shares of Senseonics Holdings Inc (NYSEAMERICAN:SENS) gapped down prior to trading on Friday . The stock had previously closed at $4.29, but opened at $3.97. Senseonics shares last traded at $3.53, with a volume of 3324872 shares traded.

Several research firms have weighed in on SENS. Dougherty & Co began coverage on shares of Senseonics in a research note on Friday, August 24th. They issued a “buy” rating and a $6.00 price target for the company. BTIG Research reissued a “buy” rating and issued a $6.00 price target on shares of Senseonics in a research note on Thursday, August 9th. Six analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of $6.00.

Senseonics (NYSEAMERICAN:SENS) last released its quarterly earnings data on Thursday, November 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The firm had revenue of $5.16 million during the quarter, compared to analysts’ expectations of $5.16 million. During the same quarter in the previous year, the firm posted ($0.13) EPS. Senseonics’s revenue was up 145.7% compared to the same quarter last year.

Several hedge funds have recently added to or reduced their stakes in SENS. Millennium Management LLC increased its position in shares of Senseonics by 43.5% in the first quarter. Millennium Management LLC now owns 1,387,566 shares of the company’s stock valued at $4,163,000 after acquiring an additional 420,358 shares during the period. Bank of Montreal Can purchased a new position in shares of Senseonics during the second quarter valued at about $1,030,000. Broadview Advisors LLC purchased a new position in shares of Senseonics during the second quarter valued at about $2,774,000. Daiwa Securities Group Inc. purchased a new position in shares of Senseonics during the second quarter valued at about $332,000. Finally, Raymond James Financial Services Advisors Inc. increased its position in shares of Senseonics by 19.6% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 651,481 shares of the company’s stock valued at $2,678,000 after buying an additional 106,679 shares during the period. Hedge funds and other institutional investors own 30.66% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2018/11/10/senseonics-sens-shares-gap-down-to-3-97.html.

About Senseonics (NYSEAMERICAN:SENS)

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Further Reading: The Discount Rate – What You Need to Know

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.